These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Schneider M; Schömig E; Leweke FM Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382 [TBL] [Abstract][Full Text] [Related]
3. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2. Radziszewska E; Bojanowska E Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632 [TBL] [Abstract][Full Text] [Related]
4. Effects of hippocampal administration of a cannabinoid receptor agonist WIN 55,212-2 on spontaneous object and place recognition in rats. Suenaga T; Ichitani Y Behav Brain Res; 2008 Jul; 190(2):248-52. PubMed ID: 18374994 [TBL] [Abstract][Full Text] [Related]
5. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice. Zhang RS; He Z; Jin WD; Wang R Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221 [TBL] [Abstract][Full Text] [Related]
6. Effects of SR141716 and WIN 55,212-2 on tolerance to ethanol in rats using the acute and rapid procedures. Lemos JI; Takahashi RN; Morato GS Psychopharmacology (Berl); 2007 Oct; 194(2):139-49. PubMed ID: 17546513 [TBL] [Abstract][Full Text] [Related]
8. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Clarke JR; Rossato JI; Monteiro S; Bevilaqua LR; Izquierdo I; Cammarota M Neurobiol Learn Mem; 2008 Sep; 90(2):374-81. PubMed ID: 18524639 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells. Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260 [TBL] [Abstract][Full Text] [Related]
10. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats. Hasanein P; Teimuri Far M Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415 [TBL] [Abstract][Full Text] [Related]
11. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Hasanein P; Parviz M; Keshavarz M; Javanmardi K Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413 [TBL] [Abstract][Full Text] [Related]
12. WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids. Barna I; Soproni K; Arszovszki A; Csabai K; Haller J Behav Pharmacol; 2007 Sep; 18(5-6):515-20. PubMed ID: 17762520 [TBL] [Abstract][Full Text] [Related]
13. Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice. Aguilar MA; Ledesma JC; Rodríguez-Arias M; Penalva C; Manzanedo C; Miñarro J; Arenas MC Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635664 [TBL] [Abstract][Full Text] [Related]
14. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084 [TBL] [Abstract][Full Text] [Related]
15. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors. Bortolato M; Frau R; Bini V; Luesu W; Loriga R; Collu M; Gessa GL; Ennas MG; Castelli MP J Psychiatr Res; 2010 Oct; 44(14):944-55. PubMed ID: 20378129 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study. Mohammadi Vosough E; Baradaran Rahimi V; Masoud SA; Mirkarimi HR; Demneh MK; Abed A; Banafshe HR; Askari VR Life Sci; 2019 Sep; 232():116670. PubMed ID: 31330139 [TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2. Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533 [TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model. Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743 [TBL] [Abstract][Full Text] [Related]
19. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2. Schneider M; Drews E; Koch M Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450 [TBL] [Abstract][Full Text] [Related]
20. Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats. Wegener N; Kuhnert S; Thüns A; Roese R; Koch M Psychopharmacology (Berl); 2008 Jun; 198(3):375-85. PubMed ID: 18446326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]